Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BONCURE: Patient Preference for Monthly Ibandronate in Postmenopausal Osteoporosis
NCT00545779Phase 3Completed
- Sponsor
- Roche
- Start
- Dec 2006
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of ibandronic acid in postmenopausal osteoporosis, sponsored by Roche. Started Dec 2006; status: completed.
02
Drugs
ibandronic acid
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00545779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00545779.